Prior to Accera, Mr. Ballantyne was the Chief Financial Officer for Agenus, Inc. where he was responsible for all aspects of finance, accounting, investor relations and corporate communications. Prior to that, he held the Chief Financial Officer role at Synthetic Biologics, Inc. and before that, he served as Executive Vice President and Chief Financial Officer of Clinical Data, Inc., a bio-pharmaceutical company focused on CNS diseases that was acquired by Forest Labs for $1.3 billion. Mr. Ballantyne has also held the position of Chief Financial Officer at several medical technology companies including Avedro, Inc. and ZymeQuest, Inc. Earlier in his career, he served as Chief Operating Officer and Chief Financial Officer at the ACNielsen Corporation. He also held held various financial positions at IMS Health and the Dun & Bradstreet Corporation. Mr. Ballantyne holds a BA from the University of Western Ontario and a post-graduate degree in honors business administration from the University of Windsor.
Business and Management